{"organizations": [], "uuid": "b87d97b069c424ab52da266bc56dc76c139cabc7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mimedx-enrolls-first-patient-in-it/brief-mimedx-enrolls-first-patient-in-its-phase-2b-clinical-trial-of-amniofix-injectable-for-treatment-of-osteoarthritis-of-the-knee-idUSASC09TYM", "country": "US", "domain_rank": 408, "title": "BRIEF-MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of Amniofix速 Injectable For Treatment Of Osteoarthritis Of The Knee", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-28T15:24:00.000+03:00", "replies_count": 0, "uuid": "b87d97b069c424ab52da266bc56dc76c139cabc7"}, "author": "", "url": "https://www.reuters.com/article/brief-mimedx-enrolls-first-patient-in-it/brief-mimedx-enrolls-first-patient-in-its-phase-2b-clinical-trial-of-amniofix-injectable-for-treatment-of-osteoarthritis-of-the-knee-idUSASC09TYM", "ord_in_thread": 0, "title": "BRIEF-MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of Amniofix速 Injectable For Treatment Of Osteoarthritis Of The Knee", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "treatment of osteoarthritis of the knee reuters", "sentiment": "none"}, {"name": "mimedx group inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News March 28, 2018 / 12:25 PM / Updated 8 minutes ago BRIEF-MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of Amniofix速 Injectable For Treatment Of Osteoarthritis Of The Knee Reuters Staff 1 Min Read \nMarch 28 (Reuters) - MiMedx Group Inc: \n* MIMEDX ENROLLS FIRST PATIENT IN ITS PHASE 2B CLINICAL TRIAL OF RMAT DESIGNATED AMNIOFIX速 INJECTABLE FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-28T15:24:00.000+03:00", "crawled": "2018-03-28T15:34:40.042+03:00", "highlightTitle": ""}